SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Osmotica Pharmaceuticals Q1 EPS $(0.050) Beats $(0.140) Estimate, Adj. EBITDA $11.1M, Sales $48.649M Beat $45.470M Estimate

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.050) per share which beat the analyst consensus estimate of $(0.140) by 64.29 percent. This is a 58.33 percent increase over losses of $(0.120) per

Benzinga · 05/12/2020 20:11

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.050) per share which beat the analyst consensus estimate of $(0.140) by 64.29 percent. This is a 58.33 percent increase over losses of $(0.120) per share from the same period last year. The company reported quarterly sales of $48.649 million which beat the analyst consensus estimate of $45.470 million by 6.99 percent. This is a 14.84 percent decrease over sales of $57.126 million the same period last year.